Follow
Nicolaus Kröger
Nicolaus Kröger
Professor der Medizin
Verified email at uke.de
Title
Cited by
Cited by
Year
Philadelphia-negative classical myeloproliferative neoplasms: critical concepts and management recommendations from European LeukemiaNet
T Barbui, G Barosi, G Birgegard, F Cervantes, G Finazzi, M Griesshammer, ...
Journal of clinical oncology 29 (6), 761, 2011
9382011
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study
SK Kumar, JH Lee, JJ Lahuerta, G Morgan, PG Richardson, J Crowley, ...
Leukemia 26 (1), 149-157, 2012
9162012
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and …
RA Kyle, BGM Durie, SV Rajkumar, O Landgren, J Bladé, G Merlini, ...
Leukemia 24 (6), 1121-1127, 2010
8842010
Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey
R Zeiser, A Burchert, C Lengerke, M Verbeek, K Maas-Bauer, ...
Leukemia 29 (10), 2062-2068, 2015
5132015
Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually
JR Passweg, H Baldomero, P Bader, C Bonini, S Cesaro, P Dreger, ...
Bone marrow transplantation 51 (6), 786-792, 2016
4932016
Antilymphocyte globulin for prevention of chronic graft-versus-host disease
N Kröger, C Solano, C Wolschke, G Bandini, F Patriarca, M Pini, A Nagler, ...
New England Journal of Medicine 374 (1), 43-53, 2016
4602016
Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party …
N Kröger, E Holler, G Kobbe, M Bornhäuser, R Schwerdtfeger, ...
Blood, The Journal of the American Society of Hematology 114 (26), 5264-5270, 2009
4312009
Indications for allo-and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015
A Sureda, P Bader, S Cesaro, P Dreger, RF Duarte, C Dufour, ...
Bone marrow transplantation 50 (8), 1037-1056, 2015
4092015
Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNet
T Barbui, A Tefferi, AM Vannucchi, F Passamonti, RT Silver, R Hoffman, ...
Leukemia 32 (5), 1057-1069, 2018
4082018
International Myeloma Working Group consensus approach to the treatment of multiple myeloma patients who are candidates for autologous stem cell transplantation
M Cavo, SV Rajkumar, A Palumbo, P Moreau, R Orlowski, J Bladé, ...
Blood, The Journal of the American Society of Hematology 117 (23), 6063-6073, 2011
3882011
Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report
JR Passweg, H Baldomero, P Bader, C Bonini, RF Duarte, C Dufour, ...
Bone marrow transplantation 52 (6), 811-817, 2017
3462017
Prophylaxis and treatment of GVHD: EBMT–ELN working group recommendations for a standardized practice
T Ruutu, A Gratwohl, T De Witte, B Afanasyev, J Apperley, A Bacigalupo, ...
Bone marrow transplantation 49 (2), 168-173, 2014
3442014
International Myeloma Working Group recommendations for the diagnosis and management of myeloma-related renal impairment
MA Dimopoulos, P Sonneveld, N Leung, G Merlini, H Ludwig, E Kastritis, ...
Journal of Clinical Oncology 34 (13), 1544-1557, 2016
3432016
Outcome of transplantation for myelofibrosis
KK Ballen, S Shrestha, KA Sobocinski, MJ Zhang, A Bashey, BJ Bolwell, ...
Biology of Blood and Marrow Transplantation 16 (3), 358-367, 2010
3172010
Revised response criteria for myelofibrosis: international Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) and European LeukemiaNet (ELN) consensus …
A Tefferi, F Cervantes, R Mesa, F Passamonti, S Verstovsek, ...
Blood, The Journal of the American Society of Hematology 122 (8), 1395-1398, 2013
3152013
Autologous stem cell transplantation followed by a dose-reduced allograft induces high complete remission rate in multiple myeloma
N Kröger, R Schwerdtfeger, M Kiehl, HG Sayer, H Renges, T Zabelina, ...
Blood, The Journal of the American Society of Hematology 100 (3), 755-760, 2002
3112002
Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel
T De Witte, D Bowen, M Robin, L Malcovati, D Niederwieser, ...
Blood, The Journal of the American Society of Hematology 129 (13), 1753-1762, 2017
2882017
Indication and management of allogeneic stem cell transplantation in primary myelofibrosis: a consensus process by an EBMT/ELN international working group
NM Kröger, JH Deeg, E Olavarria, D Niederwieser, A Bacigalupo, ...
Leukemia 29 (11), 2126-2133, 2015
2842015
Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants
JR Passweg, H Baldomero, P Bader, C Bonini, S Cesaro, P Dreger, ...
Bone marrow transplantation 50 (4), 476-482, 2015
2682015
Reduced-intensity conditioning versus standard conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete …
M Bornhäuser, J Kienast, R Trenschel, A Burchert, U Hegenbart, ...
The lancet oncology 13 (10), 1035-1044, 2012
2682012
The system can't perform the operation now. Try again later.
Articles 1–20